7Anchoring Sound to Bone: Implanting Bone-Conduction Devices

FTwo routes to the same bone: percutaneous versus active transcutaneous

Every bone-conduction implant solves one problem: deliver vibration directly to the skull so that the cochlea is driven without crossing the air-filled middle ear. They differ only in how that vibration crosses the skin. A percutaneous system uses an osseointegrated titanium fixture that pierces the skin as an abutment; the external processor snaps onto it and drives bone with no soft-tissue damping in the path. An active transcutaneous system keeps the skin intact and buries the vibrating transducer under it, driving the bone from inside while a magnet holds the external audio processor over the implant.

The clinical trade is acoustic efficiency against skin integrity. The percutaneous abutment is the most efficient coupler because nothing soft sits between metal and bone, but the lifelong skin penetration must be cared for. Active transcutaneous implants such as the Cochlear Osia and the MED-EL Bonebridge remove the open wound entirely, trading a few decibels of transcutaneous loss for a closed, low-maintenance skin envelope.[1988][2014]

TBuilding the bed: abutment fixture, the BCI lift, and bone management

The percutaneous procedure is now reliably single-stage. A small linear incision is made roughly 55 to 65 mm posterosuperior to the ear canal, the subcutaneous tissue is thinned, a guided drill creates a well in the mastoid cortex, and the osseointegrating titanium fixture with its abutment is seated in one sitting; the processor is fitted only after several weeks of osseointegration. Modern soft-tissue-preservation techniques and a dedicated skin punch let the abutment emerge through a tight, hair-free aperture, sharply reducing the skin reactions that plagued the old skin-graft designs.

Active transcutaneous implants need a recess rather than an abutment. The Bonebridge bone-conduction implant (BCI) houses a floating-mass-style transducer that must be sunk into the skull; where the bone is thin, the surgeon raises (lifts) the implant body on a transition piece to clear the sigmoid sinus or the posterior fossa dura rather than drilling dangerously deep. The newer BCI 602 cut the required drilling depth roughly in half, easing placement in children and malformed temporal bones. The Osia takes a different path: its piezoelectric actuator sits on the same BI300 osseointegrated screw used for percutaneous systems, so bone removal is minimal and the actuator simply bridges the screw to the skull surface beneath intact skin.[2023][2023][2014]

CCaring for the skin: Holgers grading and revision

Percutaneous abutments demand a shared vocabulary for the skin around them, and the Holgers scale supplies it. Grade 0 is quiet, well-healed skin; grade 1 is mild redness; grade 2 adds moistness and moderate swelling; grade 3 brings granulation tissue; and grade 4 is overt infection with cellulitis or abscess. The grade drives management: ointment and hygiene for grades 1 to 2, antibiotics and cautery of granulations for grade 3, and explantation with delayed reimplantation for grade 4. Recognising the climb early prevents most revisions.

Soft-tissue overgrowth, not infection, is the commonest reason to return to theatre. Skin creeping over the abutment can be treated with potent topical steroids, intralesional triamcinolone, or swapping in a longer abutment so it again protrudes clear of the skin; only resistant cases need flap revision with skin grafting. Active transcutaneous devices sidestep abutment skin reactions but trade them for closed-space problems such as seroma, magnet-site pressure, and wound dehiscence over the implant.[1988][2022]

CComplications and MRI safety by device

Beyond the skin, the bone-implant interface can fail: an abutment may lose osseointegration and extrude, a risk that is higher in children, in irradiated bone, and in poorly vascularised flaps. Single-stage placement, soft-tissue preservation, careful loading time before fitting, and aggressive treatment of early Holgers reactions are the levers that keep extrusion and revision rates low.

MRI safety is device-specific and must be checked before scanning. A bare osseointegrated abutment is essentially metal-only and MRI-tolerant after the processor is removed, but active transcutaneous implants contain magnets and transducers and carry strict field-strength limits, defined imaging artefact zones, and in some cases a need to remove or splint the magnet. Knowing the exact model and its labelled conditions, rather than assuming all bone-conduction implants behave alike, is the safe default.[2023][2021]